Publications by authors named "Tianshu Ren"

Claim this Profile
T
The correlation between novel antidiabetic agents utilization and hepatocellular carcinoma incidence in type 2 diabetes patients: a network meta-analysis.
Junjie Lin, Tianshu Ren, Qingchun Zhao, Qiang Tong, Jiahui Liu

Eur J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and antitumor activity study of β-carboline derivatives as selective HDAC1/2 inhibitors.
Zhiya Wang, Limeng Wu, Kaisi Yang, Yiming Qi, Zhenshu Li, Tianshu Ren

Bioorg Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity" [Bioorg. Chem. 157 (2025) 108308].
Xiaoxuan Song, Xin Tong, Kaisi Yang, Yiming Qi, Wenwu Liu, Tianshu Ren

Bioorg Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoids and immunoglobulin alone or in combination in the treatment of multisystemic inflammatory syndrome in children: a systematic review and network meta-analysis.
Junjie Lin, Qiang Tong, Hui Huang, Jiahui Liu, Ye Kang, Tianshu Ren

Front Pediatr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity.
Xiaoxuan Song, Xin Tong, Kaisi Yang, Yiming Qi, Wenwu Liu, Tianshu Ren

Bioorg Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between alactic base excess on mortality in sepsis patients: a retrospective observational study.
Jiahui Liu, Yang Chen, Bin Yang, Jiabao Zhao, Qiang Tong, Tianshu Ren

J Intensive Care· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of VEGFR2 polymorphisms with clinical outcomes of anti-angiogenesis therapy in cancer patients: A systematic review and meta-analysis.
Wenzheng Feng, Lijun Zhou, Junyao He, Yimin Wang, Jiali Cai, Tianshu Ren

Eur J Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
Shu Wang, Yingshi Zhang, Tianshu Ren, Qiong Wu, Hongyuan Lu

Cell Death Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis.
Yingshi Zhang, Xiangbo Xu, Kaisi Yang, Shuai Wang, Tianqi Zhang, Tianshu Ren

Eur J Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Chang Xu, Xudong Gao, Tianshu Ren, Hefeng Geng, Kaisi Yang

Pharmacol Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of erythropoiesis-stimulating agents on breast cancer patients: a meta-analysis.
Tong Wu, Zhenhua Tong, Tianshu Ren, Danni Xie, Xue Sun

Clin Exp Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadotropin-Releasing Hormone Agonists during Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients with Breast Cancer: A Systematic Review and Meta-Analysis.
Yuan Yuan, Chu Zhang, Xueli Lei, Tianshu Ren, Han Chen

Breast Care (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis.
Han Chen, Xin-Zhu Li, Jia-Qing Chen, Tian-Shu Ren, Ying-Shi Zhang

Medicine (Baltimore)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of inhibitors to fulvestrant for advanced breast cancer: a systematic review and meta-analysis.
Tianqi Zhang, Danni Xie, Xinhui Ye, Yinuo Wang, Xue Sun, Tianshu Ren

Future Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab.
Tianshu Ren, Hui Jia, Qiong Wu, Yan Zhang, Qun Ma

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice guidance for the use of terlipressin for liver cirrhosis-related complications.
Xingshun Qi, Zhaohui Bai, Qiang Zhu, Gang Cheng, Yu Chen, Tianshu Ren

Therap Adv Gastroenterol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients.
Yang An, Xiangbo Xu, Tianshu Ren, Zhenhua Tong, Fernando Gomes Romeiro

Int J Gen Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
Tianshu Ren, Shu Wang, Zexu Shen, Chang Xu, Yingshi Zhang

Drug Saf· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCMQA, a caffeoylquinic acid derivative alleviates NMDA-induced neurotoxicity via modulating GluN2A and GluN2B-containing NMDA receptors in vitro.
Yue Yang, Huan Gao, Wenwu Liu, Xiaowen Jiang, Zexu Shen, Tianshu Ren

Toxicol In Vitro· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
Shu Wang, Yingshi Zhang, Tianshu Ren, Qiong Wu, Hongyuan Lu

Cell Death Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
Hong-Yuan Lu, Hai-Xiao Chu, Yu-Xin Tan, Xiao-Chun Qin, Ming-Yue Liu, Tian-Shu Ren

Life Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of metformin in overweight and obese people without diabetes: a systematic review and network meta-analysis.
Fuhai Hui, Yingshi Zhang, Tianshu Ren, Xiang Li, Mingyi Zhao

Eur J Clin Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Fuhai Hui, Xiaochun Qin, Qiao Zhang, Ruolan Li, Mingyue Liu, Tianshu Ren

Biomed Pharmacother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo.
Dan-Dan Li, Chang-Hao Zhao, Huai-Wei Ding, Qiong Wu, Tian-Shu Ren

Cell Prolif· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.
Yingshi Zhang, Dandan Li, Qiyu Jiang, Shuang Cao, Huiwei Sun, Tianshu Ren

Cell Death Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis